Add BrightSurf on Google Email

Ohio State University


Peptide suppresses multiple sclerosis-like disease

Researchers at Ohio State University have developed a peptide treatment that inhibits experimental autoimmune encephalomyelitis (EAE) and suppresses the onset of multiple sclerosis-like symptoms. The treatment targets T cells by binding to CD80, preventing their activation and expansion in disease.

SourceOhio State University·JournalThe Journal of Immunology·DateAug 7, 2002

Ice coring team heads for Alaskan glaciers

An ice coring team led by Ohio State University's Lonnie Thompson aims to drill through Alaska's glaciers to retrieve ancient weather records. The expedition hopes to determine if recent climate change is part of a natural cycle or caused by human activity, with potential implications for global warming.

Patch delivers longer, deeper relief from dental pain

A recent study by Ohio State University found that the DentiPatch, a small adhesive patch containing lidocaine, delivers longer and deeper relief from dental pain. The patch's anesthetic effects last up to 45 minutes, whereas traditional gel-based treatments only last about a minute.

SourceOhio State University·JournalThe Journal of the American Dental Association·DateApr 1, 2002